keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TAT-DEF-Elk-1 TFA (TDE TFA) is a cell-penetrating peptide that inhibits Elk-1 by mimicking its DEF domain and disrupting its function. It effectively blocks Elk-1 phosphorylation and its subsequent nuclear translocation, without affecting the activation of ERK or MSK1. This compound serves as a valuable tool for investigating Elk-1's involvement in the development of neuronal plasticity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | TAT-DEF-Elk-1 TFA (TDE TFA) is a cell-penetrating peptide that inhibits Elk-1 by mimicking its DEF domain and disrupting its function. It effectively blocks Elk-1 phosphorylation and its subsequent nuclear translocation, without affecting the activation of ERK or MSK1. This compound serves as a valuable tool for investigating Elk-1's involvement in the development of neuronal plasticity [1]. |
In vitro | Elk-1 phosphorylation at Ser383/389 serves a dual role, instigating Elk-1's translocation to the nucleus and activating SRE-mediated gene expression [1]. |
In vivo | TAT-DEF-Elk-1 TFA, administered via intraperitoneal injection at a dosage of 1mg/kg daily for 14 days, exhibits antidepressant effects in mice, reducing immobility comparably to established reference antidepressants such as fluoxetine and desipramine (DMI) [1]. |
Synonyms | TDE TFA |
Molecular Weight | N/A |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TAT-DEF-Elk-1 TFA TDE TFA inhibitor inhibit